Free Trial

PTC Therapeutics (PTCT) SEC Filings & 10K Form

PTC Therapeutics logo
$39.23 -3.15 (-7.43%)
(As of 11/15/2024 ET)

Recent PTC Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
4:22 PM
ARMISTICE CAPITAL, LLC (Filed by)
PTC Therapeutics (Subject)
Form SC 13G/A
11/08/2024
9:52 AM
PTC Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
10/18/2024
9:57 AM
PTC Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/18/2024
5:35 AM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
3:45 PM
ClearPoint Neuro, Inc. (Subject)
ClearPoint Neuro, Inc. (Subject)
PTC Therapeutics (Filed by)
Form SC 13D/A
08/08/2024
3:35 PM
PTC Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/18/2024
4:20 PM
Gravier Pierre (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
2:14 PM
Gravier Pierre (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/28/2024
6:00 AM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
6:55 AM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
4:20 PM
PTC Therapeutics (Issuer)
ZELDIS JEROME B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
9:12 AM
PTC Therapeutics (Subject)
ZELDIS JEROME B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2024
6:20 AM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
4:20 PM
PTC Therapeutics (Issuer)
SOUTHWELL DAVID P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
4:20 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
2:30 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/22/2024
4:20 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:20 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:20 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
2:17 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
2:24 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
2:13 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2024
4:16 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
2:58 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
3:36 PM
PTC Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/16/2024
3:20 PM
PTC Therapeutics (Issuer)
SOUTHWELL DAVID P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:20 PM
Bell William F. Jr. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:25 PM
PTC Therapeutics (Issuer)
SCHMERTZLER MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:10 PM
Boulding Mark Elliott (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:10 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:10 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:11 PM
Gravier Pierre (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:16 PM
Okey Stephanie (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:50 PM
ARMISTICE CAPITAL, LLC (Filed by)
PTC Therapeutics (Subject)
Form SC 13G
02/14/2024
6:13 AM
PTC Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/08/2024
9:17 AM
PTC Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/30/2024
2:17 PM
PTC Therapeutics (Subject)
Utter Christine Marie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2024
2:18 PM
Almstead Neil Gregory (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2024
2:18 PM
Almstead Zheng Yang (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2024
2:25 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2024
3:30 PM
Jacobson Allan Steven (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

01/24/2024
12:11 PM
PTC Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/22/2024
3:11 PM
Jacobson Allan Steven (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2024
3:06 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:08 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:09 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:10 PM
PTC Therapeutics (Issuer)
SCHMERTZLER MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:11 PM
PTC Therapeutics (Issuer)
Utter Christine Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
7:53 AM
FMR LLC (Filed by)
PTC Therapeutics (Subject)
Form SC 13G/A
01/09/2024
4:46 PM
Almstead Zheng Yang (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:35 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:29 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:30 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:33 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:16 PM
Almstead Neil Gregory (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:17 PM
Boulding Mark Elliott (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:23 PM
PTC Therapeutics (Subject)
Utter Christine Marie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:47 PM
Almstead Zheng Yang (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:35 PM
BlackRock Inc. (Filed by)
PTC Therapeutics (Subject)
Form SC 13G/A
01/08/2024
3:37 PM
Almstead Neil Gregory (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:46 PM
PTC Therapeutics (Subject)
Utter Christine Marie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:29 PM
Boulding Mark Elliott (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:34 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:35 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
8:46 AM
PTC Therapeutics (Subject)
SCHMERTZLER MICHAEL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
8:27 AM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
2:17 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/28/2023
4:12 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
3:38 PM
Gravier Pierre (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PTCT) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners